Image for Fragment-based drug discovery

Fragment-based drug discovery

Bamborough, Paul(Contributions by)Congreve, Miles(Contributions by)Drysdale, Martin(Contributions by)Erlanson, Daniel A(Contributions by)Esch, Iwan de(Contributions by)Giannetti, Tony(Contributions by)Hann, Michael(Contributions by)Hubbard, Roderick(Contributions by)Hughes, Terry(Contributions by)Jhoti, Harren(Contributions by)Krimm, Isabelle(Contributions by)Kutchukian, Peter(Contributions by)Spry, Christina(Contributions by)Abell, Chris(Edited by)Howard, Steven(Edited by)Thurston, David(Editor-in-chief)
Part of the RSC Drug Discovery series
See all formats and editions

Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets.

With the first fragment derived drug recently being approved, this book is an invaluable resource for medicinal chemists working in academia and industry, as well as anyone interested in drug discovery techniques.

Read More
Special order line: only available to educational & business accounts. Sign In
£169.00
Product Details
Royal Society of Chemistry
1782620931 / 9781782620938
eBook (Adobe Pdf)
615.19
17/06/2015
England
English
259 pages
Copy: 20%; print: 20%